BioCrossroads

General contacts
Investor type

VC

Founded

2002

AUM

$24 M

Location

Indianapolis, Indiana, United States

Investment Ticket

$1-5 m

Investment Stage

Seed Series A

Region of investment

North America
Investor profile last updated: 21 August, 2026

Profile

BioCrossroads is a venture capital firm based in Indianapolis, Indiana, founded in 2002. The firm focuses on catalyzing growth in Indiana's life sciences sector by fostering collaboration among research institutions, global companies, and government bodies. With a small team of professionals, BioCrossroads is dedicated to advancing innovation and investment in the life sciences industry, particularly in biotechnology, pharmaceuticals, and medical devices.

The firm invests in startups and entrepreneurs within the life sciences domain, providing a supportive ecosystem that includes mentorship and funding. BioCrossroads primarily targets sectors such as biotechnology, pharmaceuticals, medical devices, and health information technology. While specific check sizes are not disclosed, the firm is actively seeking new investments and is a member of the National Venture Capital Association.

Notable investments by BioCrossroads include companies like Gate Neurosciences, MBX Biosciences, and Scioto Biosciences. These investments highlight the firm's commitment to supporting innovative companies in drug discovery, healthcare services, and biotechnology. BioCrossroads also engages with the community through events like the annual Life Sciences Summit, which focuses on advancements in AI applications for life sciences.

Industry

Biotechnology Business Services (B2B) Education Healthcare Services Medical Devices Other Pharmaceuticals Software MedTech Life Sciences HealthTech

Contacts

Name
Title
Email
Social Networks
avatar
Melanie Vuynovich Senior Director of Workforce Development, Life Sciences
Senior Director of Workforce Development, Life Sciences
m•••@•••
LinkedIn
avatar
Tara Hobson, PhD Director of Innovation Programs
Director of Innovation Programs
t•••@•••
LinkedIn
Upgrade to see contacts
avatar
WKhYZ3Ve7bldJw1G WKhYZ3Ve7bldJw1G
WKhYZ3Ve7bldJw1G
[email protected]
linkedin twitter
avatar
WKhYZ3Ve7bldJw1G WKhYZ3Ve7bldJw1G
WKhYZ3Ve7bldJw1G
[email protected]
linkedin twitter
avatar
WKhYZ3Ve7bldJw1G WKhYZ3Ve7bldJw1G
WKhYZ3Ve7bldJw1G
[email protected]
linkedin twitter
Investment-team contacts for BioCrossroads — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about BioCrossroads

BioCrossroads is a venture capital firm. It backs companies at Seed and Series A, writing tickets of $1-5 m.
BioCrossroads is located in Indianapolis, Indiana, United States.
BioCrossroads was founded in 2002.
BioCrossroads invests in companies and startups in Biotechnology, Business Services (B2B), Education, Healthcare Services, Medical Devices, Other, Pharmaceuticals, Software, MedTech, Life Sciences, HealthTech.
BioCrossroads invests in companies and startups in North America.
BioCrossroads invests in companies and startups at Seed, Series A.
BioCrossroads usually invests $1-5 m on average.
BioCrossroads has around $24m assets under management.
BioCrossroads can be reached through its website biocrossroads.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for BioCrossroads — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query BioCrossroads directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.